Real-life data on the impact of successful downstaging in patients with hepatocellular carcinoma:A Dutch Multicenter Study

Patients with Barcelona Clinic Liver Cancer intermediate stage hepatocellular carcinoma (HCC) theoretically are an excellent group to consider downstaging using locoregional therapy (LRT) since they do not have extrahepatic spread or vascular invasion. Once successful, this can change the treatment strategy from palliative to curative intention. Although downstaging therapy is suggested in guidelines, it is still not widely accepted. Moreover, studies on downstaging are mainly performed in high-incidence HCC countries. Therefore, our aim was to gain insight in therapeutic strategies in patient... Mehr ...

Verfasser: Broekhoven, Annelotte G. C.
Fiocco, Marta
Sprengers, Dave
Takkenberg, R. Bart
van Meer, Suzanne
van Erpecum, Karel J.
Ramsoekh, Dewkoemar
Verspaget, Hein W.
Burgmans, Mark C.
Osanto, Susanne
Baranski, Andrzej G.
van Hoek, Bart
Coenraad, Minneke J.
Dokumenttyp: Artikel
Erscheinungsdatum: 2021
Reihe/Periodikum: Broekhoven , A G C , Fiocco , M , Sprengers , D , Takkenberg , R B , van Meer , S , van Erpecum , K J , Ramsoekh , D , Verspaget , H W , Burgmans , M C , Osanto , S , Baranski , A G , van Hoek , B & Coenraad , M J 2021 , ' Real-life data on the impact of successful downstaging in patients with hepatocellular carcinoma : A Dutch Multicenter Study ' , European Journal of Internal Medicine . https://doi.org/10.1016/j.ejim.2021.12.009
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-27076384
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://research.vumc.nl/en/publications/2fdcda97-e83c-4c81-8151-a6895948e29c